Myriad Genetics discovers, develops, and commercializes molecular genetic tests that determine the risk of developing disease, assess disease progression, and guide treatment decisions in Oncology, Women’s Health, and Mental Health. We are a pioneer and leader in genomic research, and we are committed to advancing the science of personalized medicine and precision medicine as we refine and develop more products to address unmet medical needs.
